Management of chemotherapy adversity through Ayurveda: An experience

M. Deogade
{"title":"Management of chemotherapy adversity through Ayurveda: An experience","authors":"M. Deogade","doi":"10.4103/jacr.jacr_148_22","DOIUrl":null,"url":null,"abstract":"Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. Chemotherapy is the largely accepted treatment protocol for cancer, but it comes with an increased risk of infections and side effects. Ayurveda can be a promising adjunct therapy to minimize the adverse effects of chemoradiotherapy. A 65-year-old female who was a known case of double-vessel block suddenly developed severe abdominal pain and was treated symptomatically by a general physician. Her weight loss was consistent with multiple episodes of abdominal pain for a year after which she was diagnosed to have moderately differentiated adenocarcinoma of the cecum. The patient was managed with exploratory laparotomy (with right hemicolectomy with ileal transverse colon end-to-end anastomosis). The histopathology study reported it as a Modified Astler–Coller stage C2. Consequently, six cycles of Folfox (chemotherapy) were advised by the oncologist. Before starting the chemotherapy, Ayurveda treatment was started to combat the expected side effects of chemotherapy. The treatment protocol included Dhanyaka phanta, Suvarnamalini vasanta, Madiphala rasayana, and Guduchyadi ksheerapaka. The patient had no additional complaints during the chemotherapy and all the hematological parameters were within normal limits. The patient reported weight gain after completion of the chemotherapy. Expected side effects (hair loss, mouth sores, anorexia, diarrhea, and vomiting) were not reported during the treatment. Known side effects of chemotherapy like infection, easy bruising, bleeding, or fatigue were also not reported; therefore, the present study concludes that the side effects of chemotherapy may be controlled by Ayurveda adjunct therapy.","PeriodicalId":239185,"journal":{"name":"Journal of Ayurveda Case Reports","volume":"58 1","pages":"103 - 107"},"PeriodicalIF":0.0000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Ayurveda Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jacr.jacr_148_22","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. Chemotherapy is the largely accepted treatment protocol for cancer, but it comes with an increased risk of infections and side effects. Ayurveda can be a promising adjunct therapy to minimize the adverse effects of chemoradiotherapy. A 65-year-old female who was a known case of double-vessel block suddenly developed severe abdominal pain and was treated symptomatically by a general physician. Her weight loss was consistent with multiple episodes of abdominal pain for a year after which she was diagnosed to have moderately differentiated adenocarcinoma of the cecum. The patient was managed with exploratory laparotomy (with right hemicolectomy with ileal transverse colon end-to-end anastomosis). The histopathology study reported it as a Modified Astler–Coller stage C2. Consequently, six cycles of Folfox (chemotherapy) were advised by the oncologist. Before starting the chemotherapy, Ayurveda treatment was started to combat the expected side effects of chemotherapy. The treatment protocol included Dhanyaka phanta, Suvarnamalini vasanta, Madiphala rasayana, and Guduchyadi ksheerapaka. The patient had no additional complaints during the chemotherapy and all the hematological parameters were within normal limits. The patient reported weight gain after completion of the chemotherapy. Expected side effects (hair loss, mouth sores, anorexia, diarrhea, and vomiting) were not reported during the treatment. Known side effects of chemotherapy like infection, easy bruising, bleeding, or fatigue were also not reported; therefore, the present study concludes that the side effects of chemotherapy may be controlled by Ayurveda adjunct therapy.
通过阿育吠陀治疗化疗逆境:经验之谈
癌症是导致全球死亡的主要原因,2020 年将有近 1000 万人死于癌症。化疗是公认的癌症治疗方案,但同时也增加了感染和副作用的风险。阿育吠陀可以作为一种很有前景的辅助疗法,将化学放疗的不良反应降至最低。一名已知患有双血管阻塞的 65 岁女性突然出现剧烈腹痛,全科医师对其进行了对症治疗。她的体重减轻与一年来多次发作的腹痛相吻合,之后她被诊断出患有中度分化的盲肠腺癌。患者接受了剖腹探查术(右半结肠切除术,回肠横结肠端端吻合术)。组织病理学研究报告称其为改良 Astler-Coller C2 期。因此,肿瘤专家建议患者接受六个周期的 Folfox(化疗)。在开始化疗之前,患者接受了阿育吠陀治疗,以消除化疗的预期副作用。治疗方案包括 Dhanyaka phanta、Suvarnamalini vasanta、Madiphala rasayana 和 Guduchyadi ksheerapaka。化疗期间,患者没有其他不适症状,所有血液指标均在正常范围内。化疗结束后,患者的体重有所增加。在治疗期间,患者没有出现预期的副作用(脱发、口腔溃疡、厌食、腹泻和呕吐)。感染、易瘀伤、出血或疲劳等已知的化疗副作用也未见报道;因此,本研究得出结论,阿育吠陀辅助疗法可控制化疗副作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信